Doublet vs. Triplet Systemic Chemotherapy for High Grade Appendiceal Adenocarcinoma with Peritoneal Metastases.

Doublet vs. Triplet Systemic Chemotherapy for High Grade Appendiceal Adenocarcinoma with Peritoneal Metastases. J Gastrointest Surg. 2023 11; 27(11):2560-2562.

View in: PubMed

subject areas

Adenocarcinoma
Antineoplastic Combined Chemotherapy Protocols
Appendiceal Neoplasms
Colorectal Neoplasms
Combined Modality Therapy
Cytoreduction Surgical Procedures
Humans
Hyperthermia, Induced
Peritoneal Neoplasms
Peritoneum
Retrospective Studies
Survival Rate

authors with profiles

Ardaman Shergill
Blase Polite